Tag Archives: Afinitor

FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer

The US Food and Drug Administration (FDA) has approved everolimus (Afinitor) to treat patients with advanced pancreatic neuroendocrine tumors (pNETs).  pNETs is a rare, slow-growing form of pancreatic cancer.  In theUnited States, there are fewer than 1000 new pNET cases … Continue reading

Posted in Cancer, Pancreatic Cancer | Tagged , , , , , , , , , , , , , | Comments Off on FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer

FDA Approves the First Drug for Tuberous Sclerosis Tumors

Good news for patients with subependymal giant cell astrocytoma (SEGA).  The US Food and Drug Administration (FDA) has granted the approval for everolimus (Afinitor, Novartis) as the first medication for children and adults with SEGA who require therapeutic intervention but … Continue reading

Posted in Cancer | Tagged , , , , , | Comments Off on FDA Approves the First Drug for Tuberous Sclerosis Tumors